Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)

Autor: Eduardo M. Krieger, Luciano F. Drager, Dante M.A. Giorgi, Alexandre C. Pereira, José Augusto Soares Barreto-Filho, Armando R. Nogueira, José Geraldo Mill, Paulo A. Lotufo, Celso Amodeo, Marcelo C. Batista, Luiz C. Bodanese, Antônio C.C. Carvalho, Iran Castro, Hilton Chaves, Eduardo A.S. Costa, Gilson S. Feitosa, Roberto J.S. Franco, Flávio D. Fuchs, Armênio C. Guimarães, Paulo C. Jardim, Carlos A. Machado, Maria E. Magalhães, Décio Mion, Raimundo M. Nascimento, Fernando Nobre, Antônio C. Nóbrega, Antônio L.P. Ribeiro, Carlos R. Rodrigues-Sobrinho, Antônio F. Sanjuliani, Maria do Carmo B. Teixeira, Jose E. Krieger, Alessandro Betito, Diogo Duarte Fagundes Moia, Silvia Beatriz Paulino Cavasin de Souza, Hilton de Castro Chaves Júnior

Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

The aim of this study is to compare spironolactone versus clonidine as the fourth drug in patients with resistant hypertension in a multicenter, randomized trial. Medical therapy adherence was checked by pill counting. Patients with resistant hyperte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac253fa47698c57b78b7ddeff4cfb50
https://pubmed.ncbi.nlm.nih.gov/30105697